You are viewing: France Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The France Biopreservation Market was valued at $91.1 Million in 2024 and projected to reach to $129.1 Million by 2029, representing a compound annual growth rate of 7.2%. France's biopreservation market is positioned for steady expansion, driven by increasing investments in regenerative medicine research and clinical applications.

France Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Biopreservation Market Trends and Insights

  • This 7.2% compound annual growth rate reflects France's strengthening position in cellular and tissue preservation technologies, driven by advances in regenerative medicine and increased adoption of cryopreservation solutions across French healthcare institutions.
  • France's robust pharmaceutical and biotechnology sector continues to invest in biopreservation infrastructure, supporting both clinical applications and research initiatives. The French biopreservation landscape is characterized by growing demand for advanced preservation techniques in stem cell banking, organ transplantation, and personalized medicine.
  • France's healthcare system and research institutions are increasingly recognizing the value of biopreservation in extending the viability of biological materials, which directly supports the country's innovation agenda in life sciences.
  • Between 2024 and 2029, France is expected to see accelerated adoption of automated preservation systems and improved regulatory frameworks that facilitate market expansion..

Key Market Statistics

  • CAGR (2024-2029) 7.2% CAGR
  • Market Size, 2024 ~USD 91.1 Million
  • Forecast, 2029 ~USD 129.1 Million
  • Country France

France Biopreservation Market Overview

Market Valuation :

France's biopreservation market is valued at $91.1 million in 2024, with projections reaching $129.1 million by 2029, representing a robust 7.2% CAGR over the forecast period.

Regenerative Medicine Growth :

French healthcare institutions are increasingly adopting biopreservation technologies to support regenerative medicine initiatives, driving demand for advanced cellular and tissue preservation solutions.

Cryopreservation Adoption :

Healthcare providers across France are expanding cryopreservation capabilities, with growing investment in infrastructure and technology to support stem cell banking and therapeutic applications.

Regulatory Support :

France's alignment with EU biopreservation standards and favorable regulatory environment for advanced medical technologies are accelerating market expansion and innovation in the sector.

France Biopreservation Market Dynamics

  • The country's robust healthcare infrastructure and strong emphasis on biotechnology innovation create favorable conditions for market growth.
  • French hospitals and research institutions are progressively integrating cryopreservation and cellular preservation technologies into their operations, supported by government initiatives promoting advanced medical solutions. The 7.2% CAGR reflects France's growing recognition of biopreservation's critical role in modern therapeutics.
  • With expanding applications in stem cell therapy, tissue engineering, and personalized medicine, the market is expected to attract significant capital investment.
  • Collaboration between French pharmaceutical companies, research centers, and healthcare providers will further accelerate adoption, positioning France as a key European hub for biopreservation innovation through 2029..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • France's biopreservation market is valued at $91.1 million in 2024 and will reach $129.1 million by 2029, representing a 7.2% CAGR.
    • France is leveraging advances in regenerative medicine and stem cell banking to drive biopreservation adoption across healthcare and research sectors.
    • France's strong pharmaceutical and biotechnology infrastructure supports investment in cryopreservation and automated preservation technologies.
    • Regulatory improvements and increased clinical applications in organ transplantation are expected to accelerate France's biopreservation market growth through 2029.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    France Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    FRANCE: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS68.375.880.186.594.1101.9110.5120.18.4
    GENE BANKS37404347505458637.9
    HOSPITALS30323537394245486.5
    OTHER END USERS19202223252628306.4
    TOTAL154.3167.8180.1193.5208.1223.9241.5261.17.7

    Target Audience

    • Biopreservation Equipment Manufacturers : Manufacturers need France-specific market data to identify growth opportunities, assess competitive positioning, and develop localized product strategies for the French healthcare sector.
    • Healthcare Providers & Hospitals : French hospitals and medical institutions require market insights to evaluate biopreservation technology investments, benchmark against peers, and plan infrastructure expansion for cellular preservation capabilities.
    • Pharmaceutical & Biotech Companies : French and international pharma companies need market intelligence to support R&D investments in regenerative medicine, identify partnership opportunities, and plan clinical trial infrastructure in France.
    • Investment & Private Equity Firms : Investors targeting the French biotech sector require detailed market analysis to identify high-growth opportunities, evaluate portfolio companies, and assess market potential for biopreservation ventures.
    • Healthcare Policy & Government Bodies : French healthcare authorities and policy makers need market data to inform regulatory frameworks, funding decisions, and strategic initiatives supporting biopreservation innovation and adoption.

    Reasons to Buy this Report

    • France-Specific Market Sizing : Obtain precise valuation data for France's biopreservation market with detailed 2024-2029 forecasts, enabling accurate budgeting and investment planning tailored to the French market landscape.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to France, including key players, market share distribution, and strategic positioning within French healthcare and biotech sectors.
    • Regulatory & Compliance Insights : Access France-specific regulatory requirements, EU compliance standards, and healthcare policies affecting biopreservation adoption and market entry strategies in the French market.
    • Growth Driver Analysis : Identify the unique factors driving France's 7.2% CAGR, including regenerative medicine adoption, healthcare infrastructure investments, and institutional demand for preservation technologies.
    • Strategic Market Entry : Develop informed go-to-market strategies for France with localized insights on healthcare provider preferences, reimbursement models, and partnership opportunities within the French biopreservation ecosystem.

    Frequently asked questions

    What is the current size of France's biopreservation market?

    France's biopreservation market was valued at $91.1 million in 2024 and is projected to grow to $129.1 million by 2029.

    What is the growth rate of France's biopreservation market?

    France's biopreservation market is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

    What are the main drivers of biopreservation growth in France?

    Key drivers include advances in regenerative medicine, increased stem cell banking initiatives, growing organ transplantation demand, and France's strong biotechnology sector investment.

    Which applications are leading France's biopreservation market expansion?

    Stem cell preservation, organ and tissue banking, and personalized medicine applications are among the leading segments driving France's biopreservation market growth.

    How does France's biopreservation market compare to global trends?

    France's 7.2% CAGR is slightly below the global average of 9.8%, reflecting a more mature but steady market with strong regulatory oversight and established healthcare infrastructure.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status